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http://dx.doi.org/1young athletes discovered to have ventricular arrhythmias (VAs) during the preparticipation
screening program for competitive sports. One hundred forty-ﬁve athletes (mean age 17 – 5
years) were evaluated. The study protocol included electrocardiography (ECG), exercise
testing, 2-dimensional and Doppler echocardiography, 24-hour Holter monitoring, signal-
averaged ECG, and in selected cases contrast-enhanced cardiac magnetic resonance
imaging. Results of ECG were normal in most athletes (85%). VAs were initially detected
prevalently during exercise testing (85%) and in the remaining cases on ECG and Holter
monitoring. Premature ventricular complexes disappeared during exercise in 56% of
subjects. Premature ventricular complexes during Holter monitoring averaged 4,700 per
day, predominantly monomorphic (88%), single, and/or in couplets (79%). The most
important echocardiographic ﬁndings were mitral valve prolapse in 29 patients (20%),
congenital heart disease in 4 (3%), and right ventricular regional kinetic abnormalities in 5
(3.5%). On cardiac magnetic resonance imaging, right ventricular regional kinetic abnor-
malities were detected in 9 of 30 athletes and were diagnostic of arrhythmogenic right
ventricular cardiomyopathy in only 1 athlete. Overall, 30% of athletes were judged to have
potentially dangerous VAs. In asymptomatic athletes with prevalently normal ECG, most
VAs can be identiﬁed by adding an exercise test during preparticipation screening. In
conclusion, cardiac screening with noninvasive examinations remains a fundamental tool for
the identiﬁcation of a possible pathologic substrate and for the characterization of electrical
instability.2013 Elsevier Inc. (AmJ Cardiol 2013;111:557e562)Open access under CC BY-NC-ND license. Athlete’s heart is generally regarded as a benign elec-
troanatomic remodeling due to systematic training. Never-
theless, repolarization inhomogeneity of myocardium,
a high prevalence of ventricular arrhythmias (VAs), and
arrhythmogenic right ventricular (RV) cardiomyopathye
like phenotypes have been described in some athletes.1e5
Sports are associated with an increased risk for sudden death
in athletes who are affected by cardiovascular conditions
predisposing to life-threatening VAs during exercise.6 The
incidence of sudden cardiac death in young competitive
athletes has substantially decreased in the Veneto region of
Italy thanks to the introduction of a preparticipation
screening program that identiﬁes subjects with previously
unrecognized cardiovascular conditions.7 Rhythm and
conduction abnormalities are the ﬁrst cardiovascular causes
of sports disqualiﬁcation, and evaluation of VAs constitutes
an important medical and legal issue.7 The aim of this studyf Cardiac, Thoracic and Vascular Sciences, and bDe-
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Open access under CC BY-NC-ND license. was to analyze using noninvasive cardiac examinations
a series of young athletes discovered to have VAs.
Methods
One hundred forty-ﬁve young, nonelite, competitive
athletes (mean age 17.3  5.3 years, range 9 to 34; male/
female ratio 106/39 ¼ 2.7) were evaluated in our laboratory
during a period of 3 years. All subjects were referred
because of VAs detected during preparticipation screening,
which also included exercise testing. The study protocol
included family and personal histories, 12-lead electrocar-
diography (ECG), 2-dimensional echocardiography with
Doppler analysis, 24-hour Holter monitoring, exercise
testing, signal-averaged ECG, and in selected cases contrast-
enhanced cardiac magnetic resonance imaging.
Electrocardiograms were evaluated using digital calipers
at standard paper speed (25 mm/s). Electrocardiographic
abnormalities were divided into 2 groups (common or
training-related and uncommon or training-unrelated
abnormalities) and interpreted considering the most recent
recommendations.8,9 Signal-averaged ECG was performed
using a MAC15 system (Marquette Inc., Milwaukee, Wis-
consin). The following parameters for each of the 3 ﬁlters
(25, 40, and 80 to 250 Hz) were evaluated: ﬁltered QRS
duration, high-frequency low-amplitude signal duration in
the terminal portion of the ﬁltered QRS interval with
a voltage amplitude <40 mV (or <20 mV for the 80- towww.ajconline.org
Table 1
Most frequent echocardiographic ﬁndings detected in the 145 athletes
Finding n (%)
Speciﬁc ﬁndings (n ¼ 36)
Mitral valve prolapse 29 (20%)
Congenital heart diseases* 4 (2.7%)
Suspected arrhythmogenic RV cardiomyopathy 3 (2.1%)
Nonspeciﬁc ﬁndings (n ¼ 72)†
Atrial septal aneurysm 3 (2.1%)
Apical RV hypokinesia 2 (1.4%)
Pericardial effusion 1 (0.7%)
LV false tendon (1) 32 (22%)
RV enlargement 11 (7.6%)
LV enlargement 9 (6.2%)
Biventricular enlargement 6 (4.1%)
Mild pulmonary regurgitation 12 (8.4%)
Mild tricuspid regurgitation 8 (5.5%)
Mild mitral regurgitation without prolapse 3 (2.1%)
Mild aortic regurgitation 2 (1.4%)
Isolated left papillary muscle hypertrophy 1 (0.7%)
* Bicuspid aortic valve with mild valvular stenosis, ventricular septal
defect, partial anomalous pulmonary venous return, and persistent left
superior vena cava; a Wolff-Parkinson-White electrocardiographic pattern
was also found.
† More than 1 nonspeciﬁc ﬁnding was present in some subjects.
558 The American Journal of Cardiology (www.ajconline.org)250-Hz ﬁlter), and the root mean square of the voltage in the
last 40 ms of the ﬁltered QRS interval. Presence of late
potentials was considered when 2 parameters were
abnormal in 1 ﬁlter. The exercise test was performed on
a bicycle or treadmill (with standard 12-lead placement) up
to the submaximal heart rate, calculated from the formula
220  age  85%. ST-segment alterations and VAs were
carefully evaluated. Holter monitoring was performed using
12-lead ECG (with standard lead placement). The number,
morphologies, and coupling intervals of single and repeti-
tive VAs were studied.
The echocardiographic study was performed with a 2.5-
to 4-MHz transducer (model 5500, Philips Medical Systems,
Andover, Massachusetts) and included M-mode, 2-dimen-
sional, and Doppler examinations of the traditional views.
Left ventricular (LV) end-diastolic diameter, parietal wall
thickness, and left atrial diameter were calculated in the
parasternal long-axis view using M-mode imaging. LV end-
diastolic volume, end-systolic volume, and ejection fraction
were calculated in the apical 4-chamber view (using Simp-
son’s rule). RV end-diastolic area, end-systolic area, and
fractional area change were calculated from the apical
4-chamber view, and the RV ejection fraction was also
measured. The RV outﬂow tract was measured in the par-
asternal view and the short-axis view and the RV inﬂow
tract in the 4-chamber view. The presence of LV and RV
wall motion abnormalities was assessed.
Cardiac magnetic resonance imaging was performed
using a 1.0-T clinical scanner (Harmony; Siemens Health-
care, Erlangen, Germany) using a phased-array cardiac
receiver coil. After the intravenous administration of gado-
linium, chelate inversion recovery prepared, breath-hold
cine gradient-echo images were obtained. Cine, morpho-
logic, and late gadolinium enhancement images acquired
during the same imaging session were matched by slice
position.
Data are expressed as mean SD for continuous variables
and as frequencies with percentages for categorical variables.
All continuous variables are expresses as mean  SD.
Results
The initial detection of premature ventricular complexes
(PVCs) during the preparticipation program was due mostly
to the exercise tests in 124 athletes (85%). In the remaining
cases, PVCs were present on ECG (7 athletes [5%]) or
detected on Holter monitoring (14 athletes [10%]).
Baseline electrocardiographic results were normal in 123
athletes (85%) (in 90 [62%] with the common abnormali-
ties) and abnormal in 22 (15%) with the uncommon
abnormalities. Mean values of rhythm (69  11 beats/min),
electrical QRS axis (73  2), PQ interval (147  22 ms),
QRS duration (93  14 ms), corrected QT interval (414 
19 ms), and isolated QRS voltage criteria for LV hyper-
trophy (SV1 þ RV5/V6 ¼ 27  8 mV) were normal.
All athletes were in sinus rhythm. A mild right axis devia-
tion of the QRS complex (þ105), present in 15 athletes
(10.3%), was considered normal. The electrocardiographic
common abnormalities were sinus bradycardia in 28 athletes
(19.3%), ﬁrst-degree atrioventricular block in 4 (2.8%),
incomplete right bundle branch block (RBBB) in 37(25.5%), isolated increases in QRS voltage in 17 (11.7%),
and early repolarization in 50 (34.5%). The electrocardio-
graphic uncommon abnormalities were left or right atrial
enlargement in 4 athletes (2.8%), ventricular preexcitation in
1 (0.7%), complete RBBB in 3 (2.1%), signs of RV
hypertrophy in 2 (1.4%), nondiagnostic Brugada-like ST-
segment abnormalities in 4 (2.8%), ST-segment depression
in 2 (1.4%), T-wave inversions in 8 (5.5%), and corrected
QT interval prolongation in 3 (2.1%; 450 to 460 ms, male
athletes). Normal T waves were present in 137 athletes
(94.5%). Negative T waves in lead V1 were present in 99
athletes (68.2%) but were rare in other precordial leads: V1
to V2 (2.1%; age 14 years), V1 to V3 (1.4%), V1 to
V4 (0.7%), lateral leads (0.7%), and 2 inferior leads
(1.4%). Intraventricular conduction delays with QRS dura-
tions >120 ms were present in 4 athletes always, in
conjunction with negative T waves in >1 precordial or
inferior lead. VPCs were present on ECG in 33 athletes
(22.7%).
Signal-averaged ECG was performed in 129 athletes
(89%). Ten (6.9%) showed late potentials: 6 in 1 ﬁlter and 4
in 2 ﬁlters. The mean values of each ﬁlter were normal:
ﬁltered QRS duration 120.1  11.4, 110.9  14.8, and
97.1 13 ms; high-frequency low-amplitude signal duration
17.8 10.4, 28.8 26.9, and 25.1 11.3 ms; and root mean
square of the voltage in the last 40 ms of the ﬁltered QRS
interval 105.6  58.3, 50.5  22.3, and 34.7  23.6 mV.
Concerning echocardiographic alterations, typical
ﬁndings of athlete’s heart were detected in 38 subjects
(26%; Table 1). In detail, LV end-diastolic diameter was
increased (>56 mm) in 10% (mean 50 5 mm), and ejection
fractions were normal (mean 61 4%) in all but 1. None had
a parietal wall thickness >11 mm (septal wall 8  1.2 mm,
posterior wall 7.8  1.2 mm). E/A ratios were normal in all
(E ¼ 82  13 cm/s, A ¼ 44  12 cm/s) but 1 subject. Ea/Aa
Figure 1. The most frequent morphologies of PVCs in our cohort of athletes. The ﬁrst 5 cases of PVCs were characterized by LBBB morphology with variable
axis deviation, and the next 4 cases of PVCs were characterized by RBBB morphology with variable axis deviation.
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cm/s, Aa ¼ 7.9  2.3 cm/s, Sa ¼ 11.5  2.9 cm/s). Left or
right atrial enlargement was present in 10 athletes (6.9%).
The presence of 1 LV false tendon was detected in 22%.
RV enlargement (RV end-diastolic area >24 cm2) was
present in 17% (mean 21  4 cm2). The RV inﬂow tract was
increased in size (>41 mm) in 19%. The RV outﬂow tract in
the parasternal view was increased in size (19 mm/m2) in 3
athletes, and the RV outﬂow tract in the short-axis view was
increased in size (21 mm/m2) in 2 athletes. RV systolic
function was normal (fractional area change 45.5  5.5%,
ejection fraction 61.1  4.6%) in all but 1 subject. Rich
trabeculation (29%), globular-shaped apex (16%), and
hyperechogenic moderator band (16%) were quite common.
RV Ea/Aa ratios, assessed in 63 athletes, were normal in all
(Ea¼ 14.9 3.3 cm/s, Aa¼ 8.2 2.9 cm/s, Sa¼ 13.1 2.6
cm/s). Trivial regurgitations were detected in the tricuspid
valve (75%), the mitral valve (63%), the pulmonary valve
(41%), and the aortic valve (11%). One athlete had mild
pulmonary hypertension. Mitral valve prolapse was found
in 29 athletes (20%; 4 with mild regurgitation). Congenital
heart disease was detected in 4 athletes (2.8%; a bicuspidaortic valve, a ventricular septal defect, a partial anomalous
pulmonary venous return, and a persistent left superior vena
cava). The suspicion of arrhythmogenic RV cardiomyopathy
was raised in 3 subjects (2.1%), and isolated RV apical
hypokinesia was found in another 2 (1.4%).
Holter monitoring showed a mean number of PVCs of
4,700 per day. The number of PVCs ranged from 0 to 720
per day in 49 athletes (33.8%), from 720 to 5,000 per day in
46 (31.7%), from 5,000 to 10,000 per day in 29 (20%), and
from 10,000 to 20,000 per day in 17 (11.7%) and
was >20,000 per day in 4 (2.8%). In 26 subjects (18%),
PVCs numbered <20 per day and were judged nonsigniﬁ-
cant. Only single PVCs were detected in 83 athletes (57%),
and in the remaining athletes, repetitive forms were also
detected (43%). Single PVCs had in 98% of subjects wide
coupling intervals (>400 ms, mean 506  104 ms). Among
the 119 athletes with signiﬁcant numbers of PVCs, in 105
(88%), PVCs were monomorphic. The most frequent PVC
morphologies were left bundle branch block (LBBB) with
inferior axis deviation (IAD) in 59 subjects (50%), RBBB
with left axis deviation (LAD) in 21 (18%), LBBB with
LAD in 18 (15%), RBBB with right axis deviation in 14
Figure 2. Flow diagram demonstrating the workout and results of cardiologic screening. In 43 athletes (30%), VAs were judged to be potentially dangerous on
the basis of the arrhythmic pattern (complex idiopathic VAs or VAs triggered by mild abnormalities) and/or the presence of organic heart disease or nonspeciﬁc
abnormalities on cardiac magnetic resonance imaging (CMR) that diagnosis was not deﬁnite. The box labeled “deﬁnitive diagnosis of organic heart disease”
included 4 congenital diseases/abnormalities, 1 arrhythmogenic RV cardiomyopathy, and 1 pericardial effusion. The box labeled “mild abnormalities” mostly
included mitral valve prolapse and also mild mitral regurgitation, atrial septal aneurysm, RV apical hypokinesia, 1 case of mild aortic regurgitation, and 1 case
of moderate LV enlargement. The box labeled “idiopathic ventricular arrhythmias” included VAs in the absence of structural disease or VAs not related to the
type of abnormality. VPC ¼ premature ventricular complex.
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with IAD in 8 (7%) (Figure 1). IAD was considered
between þ75 and þ105 and LAD 30. A total of 44
athletes (30%) showed ventricular couplets (monomorphic
in 32, polymorphic in 12), with a mean coupling interval of
457  181 (<400 ms in 11 [24%]); in 5 subjects, ventricular
couplets were frequent (>100 per day), and in 1 case, they
were frequent and short coupled. Asymptomatic, non-
sustained ventricular tachycardia (VT) was present in 31
athletes (21%). Of these, 27 showed brief VT (3 to 10
beats): 17 presented triplets (mean rate 138 beats/min)
and 10 presented runs from 4 to 10 beats (mean rate 170
beats/min). In 4 athletes, VT episodes of >10 beats were
observed. Most athletes (n ¼ 22 [71%]) showed single runs
of VT during the day. The mean ventricular rate of all VTs
was 130 beats/min (mean R-R interval 461 ms): 4 VTs
(13%) with rates >210 beat/min, 9 (33%) with rates of 150
to 210 beats/min, 11 (35%) with rates of 100 to 150 beats/
min, and 7 (22.5%) with rates <100 beats/min. Moreover, 4
athletes presented short runs of polymorphic VT. Overall,
13 VTs (9%) were judged potentially dangerous on the basis
of electrocardiographic characteristics (short R-R interval,
multiple or long episodes, polymorphism, exercise induc-
tion) or the presence of an organic substrate.10e12
Submaximal exercise tests were performed in 138
athletes (95%), and in 124 (90%), PVCs were recorded.
Four basic patterns of PVC response to effort were found:
(1) PVCs that disappeared during effort, reappearing during
the recovery phase in 77 athletes (55.8%), (2) PVCs that
appeared only during the recovery phase in 16 (11.6%), (3)PVCs that persisted during all exercise in 12 (8.7%), and (4)
exercise-induced PVCs in 19 (13.8%) (3 with repetitive
forms; in 15 cases, PVCs were totally absent at rest during
Holter monitoring). Effort-induced PVCs showed LBBB
morphology with IAD in 7 athletes (37%), RBBB with LAD
in 6 (31%), LBBB with LAD in 3 (16%), LBBB with
normal axis in 1 (0.7%), and RBBB with right axis deviation
in 1 (0.7%). In 1 athlete, polymorphic PVCs were present.
Supraventricular arrhythmias were present in 3.6%. No
signiﬁcant ST-T changes were recorded.
Thirty athletes underwent contrast-enhanced cardiac
magnetic resonance imaging. Results were normal in 14; in 3,
results conﬁrmed a left superior vena cava, a partial anoma-
lous pulmonary venous return, and a hypertrophic papillary
muscle, and in 1 subject, mild septal late enhancement was
present. Twelve athletes had1 RV abnormal ﬁnding: 1 with
moderate RV enlargement and 2 with mild diffuse hypo-
kinesia. In 9 athletes, the presence of regional wall motion
abnormalities was detected: apical hypokinesia in 3, RV
systolic bulging in 3, akinetic regions in 2, and a dyskinetic
region in 1. Among these subjects, 2 also showed late
enhancement, and 3 showed regional fatty inﬁltrations. Only
1 subject presented with regional dysfunction plus a structural
alteration (1 minor criterion for arrhythmogenic RV cardio-
myopathy diagnosis).13
After clinical evaluation, 30% of athletes were judged to
have potentially dangerous VAs on the basis of the presence
of a morphologic substrate and/or the characteristics of
VA pattern according to the recommendations for compet-
itive sports, tailored to each athlete and type of sport10e12
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diagnosis between athlete’s heart and arrhythmogenic RV
cardiomyopathy were also judged potentially dangerous.
Among these athletes, 10% (n ¼ 14) were treated with
antiarrhythmic drugs, in 1.4% (n ¼ 2) ablation was indi-
cated, and in 1 athlete surgical repair of the congenital
defect was indicated. In the rest of the athletes, competitive
sports were not recommended, and detraining was proposed
(n ¼ 26). Follow-up was feasible in 93 athletes (mean 28
months). A decrease of >70% in the number of PVCs
compared to the ﬁrst Holter monitoring was observed in 34
(37%), while in 31 (33%), VAs did not show signiﬁcant
changes, and in 28 (30%), PVCs increased. During follow-
up, no athlete presented with a major cardiac event.
Discussion
The research for a morphologic substrate in athletes with
VAs is usually the primary goal, determining both the
prognosis and recommendation for sports participation.
Most VAs are not associated with underlying cardiac
abnormalities, appearing to be an expression of “athlete’s
heart syndrome,” but in athletes with frequent and complex
VAs, the prevalence of structural heart disease is higher.14
Concealed cardiomyopathies and primary electrical disor-
ders are important causes of sudden death, and “benign”
VAs could be the ﬁrst expression of an early form of car-
diomyopathy.15e19 Long-term follow-up studies in subjects
with outﬂow tract VAs showed a benign prognosis.20,21
Nevertheless, potentially dangerous VAs in an apparently
normal heart may create eligibility difﬁculties, evaluation
becomes challenging, and careful, multiparametric analysis
of all data should be performed.10e12,22,23
In this series, exercise testing performed during pre-
participation screening was fundamental for PVC detection,
because most athletes (85%) were referred for cardiologic
screening because of PVC detection during the test. Soﬁ
et al24 also found cardiac anomalies on exercise testing of
athletes with normal ﬁndings on rest ECG. This is because
an exercise test allows the monitoring of rhythm for a vari-
able period of time. In our experience, 4 patterns of PVC
response to exercise were found, with the most prevalent
being the suppression of PVCs by exercise.
VAs were predominantly associated with normal results
on ECG (85%; in 62% with common abnormalities). Early
repolarization was the most common ﬁnding, and even if its
signiﬁcance in athletes with VAs is not yet completely clear,
malignant early repolarization was not present.25,26
Abnormal results on ECG were infrequent (15%), and only
5% presented frankly pathologic electrocardiographic
alterations. It is noteworthy that negative T waves beyond
lead V2 are usually considered a marker of disease, and this
was conﬁrmed by our study, as all 3 athletes with negative T
waves from leads V1 to V3 or V4 (2.1%) were ultimately
diagnosed with structural heart disease (partial anomalous
pulmonary venous return, arrhythmogenic RV cardiomy-
opathy, and accessory pathway).27 Diagnostic channelo-
pathic electrocardiographic features were not present, and
borderline ﬁndings on ECG were rare (5%) and judged as
electrocardiographic variants.9 The appearance of PVCs on
23% of electrocardiograms can be considered a marker ofmore frequent ectopy at all times, as all subjects showed
frequent PVCs on Holter monitoring. The presence of late
potentials was quite rare, and subjects with late potentials
did not show the presence of signiﬁcant VAs or echocar-
diographic alteration. Nonetheless, it may be useful for risk
stratiﬁcation, and the absence of late potentials is still an
important ﬁnding.28
Analysis of VAs on Holter monitoring showed that PVCs
were often frequent, monomorphic, single, and/or in
couplets, with wide coupling intervals (Figure 1). Couplets
were present in 30% of athletes and were usually rare and
monomorphic, with wide coupling intervals. VTs were
present in 21%, all nonsustained, usually as single and brief
runs during the day; in only 2.8% of cases were VTs fast.
VAs were more frequently idiopathic (n ¼ 119 [82%]) and
in 12% of subjects (n ¼ 20) were judged as a severe pattern
(Figure 2).
The most frequent pathologic echocardiographic ﬁnding
was mitral valve prolapse (20%; Table 1). Importantly, most
subjects with mitral valve prolapse had normal results on
ECG, and in 38%, prolapse was associated with VAs of
RBBB morphology at rest or during effort, which could be
a limiting factor for sports eligibility in some athletes.
Regarding the presence of kinetic abnormalities, 6 athletes
showed RV regional kinetic abnormalities (4.1%). Of these,
3 athletes were suspected to have a possible form of
arrhythmogenic RV cardiomyopathy (with a deﬁnite diag-
nosis in only 1). One athlete showed a partial anomalous
venous pulmonary return, and 2 had isolated RV apical
hypokinesia. Additionally, 2 congenital heart diseases
(bicuspid aortic valve and ventricular septal defect) were
identiﬁed in the presence of normal results on ECG.
Regarding the results of cardiac magnetic resonance
imaging, the signiﬁcance of localized abnormalities in terms
of diagnosis and prognosis is not currently known. In patients
with RV arrhythmias, RV focal fatty replacement may be
present, and although a recent study demonstrated that the
presence of RV abnormalities is associated with worse
outcomes, more follow-up studies are needed to clarify the
nature of RV abnormalities in athletes.19,20,29 From our
cohort, in 9 subjects, localized RV morphofunctional
abnormalities were detected, but only 1 fulﬁlled the magnetic
resonance criteria for arrhythmogenic RV cardiomyopathy.13
In the remaining cases, diagnosis and the decision for sports
eligibility remain challenging, and careful clinical manage-
ment and close follow-up are mandatory if invasive investi-
gations are not undertaken.1,4,18,19,28
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